Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Double Simulation, Positive Drug and Placebo Parallel Control Phase III Clinical Trial And Open-label Extension Trial of YJ001 for Spray Use the Treatment of Diabetic Peripheral Neuropathic Pain

NCT07859111 is registered in ClinicalTrials.gov with Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT07859111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07859111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Double Simulation, Positive Drug and Placebo Parallel Control Phase III Clinical Trial And Open-label Extension Trial of YJ001 for Spray Use the Treatment of Diabetic Peripheral Neuropathic Pain
Lead sponsor
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
Phase
Phase 3
Overall status
Recruiting
Start date
August 3, 2026
Completion date
August 30, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain (dpnp)